News
WEDNESDAY, Oct. 16, 2024 (HealthDay News) -- For patients with stage III or IV Hodgkin lymphoma, nivolumab with doxorubicin, vinblastine, and dacarbazine (N+AVD) yields longer progression-free ...
Evaluation of the Childhood Hodgkin International Prognostic Score (CHIPS) in High‐Risk Pediatric Hodgkin Lymphoma Patients Treated on Children's Oncology Group AHOD1331, Pediatric Blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback